What we’ve been up to…

In the last couple of months: Montfort completes raising 250,000 USD in seed round from private investors. Montfort obtains “New Companies” grant, our third program with the Israeli Innovation Authority. Montfort recognized as an R&D company under the “Angel Law”.

Read More...

Montfort-THM commercialization agreement

In continuum to our collaboration, Montfort signs a commercialization agreement with Tel Hashomer Medical Research, Infrastructure and Services Ltd (THM) for the development of AppTUG-based NPH diagnosis tool. By using AppTUG, before and after lumbar puncture (LP), we are able to accurately measure the impact of the intracranial pressure reduction.

Read More...

AppTUG launched in Assaf Harofeh hospital

Montfort starts working in Assaf Harofeh hospital in collaboration with The Sagol Center for Hyperbaric Medicine and research. The hyperbaric chambers in the Sagol Center provide High Pressure Oxygen Treatment (HBOT), which helps treating patients who suffer from different acute or chronic medical conditions. AppTUG is used for motor assessments of patients who suffer from

Read More...

Monitoring in Shaare Zedek Medical Center

Montfort AppTUG is being used in the Gaucher’s disease center in Shaare Zedek Medical Center, Jerusalem, Israel. Gaucher’s disease is caused by a recessive mutation in the GBA gene located on chromosome 1 and affects both males and females. About one in 100 people in the United States are carriers of the most common type

Read More...

Monitoring Parkinson’s disease in Sheba Medical Center

Montfort AppTUG is being used during treatment of Parkinson’s disease (PD) patients, in Sheba medical center. Parkinson’s disease is aneurological disorder that mainly affects the motor system. Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking. PD affects approximately seven million people globally and one million people

Read More...